Hyper-igm Syndrome
📧 Sign up to get email alerts when something new happens for Hyper-igm Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies [NA]
This clinical trial investigates allogeneic hematopoietic stem cell transplantation as a treatment for primary immune deficiencies, includin…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases [Phase 1, Phase 2]
This clinical trial update describes an early-phase study evaluating sequential cadaveric lung transplantation followed by bone marrow trans…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States
A National Institute of Allergy and Infectious Diseases-sponsored clinical trial investigating Hyper-IgM Syndrome and Ectodermal Dysplasia w…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases [Phase 3]
A Phase 3 bioequivalence study comparing Gammaplex 10% and Gammaplex 5% intravenous immunoglobulin in patients with primary immunodeficiency…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency [Phase 4]
Phase 4 study evaluating the safety and effectiveness of Gammaplex in youths with primary immunodeficiency disorders, including Common Varia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. [Phase 3]
Phase 3 study evaluating the efficacy, safety, and pharmacokinetics of Gammaplex in primary immunodeficiency diseases completed with results…